The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125519822 12551982 2 F 20160617 20160718 20160713 20160802 EXP GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-120095 RANBAXY 72.00 YR F Y 80.00000 KG 20160802 CN GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125519822 12551982 1 PS Atorvastatin ATORVASTATIN 1 Unknown UNK U U 76477
125519822 12551982 2 C AMITRIPTYLINE HYDROCHLORIDE. AMITRIPTYLINE HYDROCHLORIDE 1 Unknown 2 DF, QD, AT NIGHT 1246 DF U U 0 2 DF
125519822 12551982 3 C AMOXICILLIN. AMOXICILLIN 1 Unknown 1 DF, TID 260 DF U U 0 1 DF Q8H
125519822 12551982 4 C ASPIRIN. ASPIRIN 1 Unknown 1 DF, QD, EACH MORNING 42 DF U U 0 1 DF
125519822 12551982 5 C BENDROFLUMETHIAZIDE BENDROFLUMETHIAZIDE 1 Unknown 1 DF, QD, IN THE MORNING 623 DF U U 0 1 DF
125519822 12551982 6 C CALCIUM CARBONATE. CALCIUM CARBONATE 1 1 DF, BID 658 DF U U 0 1 DF Q12H
125519822 12551982 7 C IBUPROFEN. IBUPROFEN 1 Topical APPLY 3-4 TIMES A DAY U U 0
125519822 12551982 8 C LISINOPRIL. LISINOPRIL 1 Unknown 1 DF, QD 623 DF U U 0 1 DF
125519822 12551982 9 C PIROXICAM. PIROXICAM 1 Topical APPLY AS DIRECTED U U 0
125519822 12551982 10 C SEREVENT DISKUS SALMETEROL XINAFOATE 1 Respiratory (inhalation) 2 DF, BID 2492 DF U U 0 2 DF Q12H
125519822 12551982 11 C VENTOLIN ALBUTEROL SULFATE 1 Respiratory (inhalation) 2 DF, BID, AS REQUIRED 4984 DF U U 0 2 DF Q6H

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125519822 12551982 1 Product used for unknown indication
125519822 12551982 2 Product used for unknown indication
125519822 12551982 3 Product used for unknown indication
125519822 12551982 4 Product used for unknown indication
125519822 12551982 5 Product used for unknown indication
125519822 12551982 6 Product used for unknown indication
125519822 12551982 7 Product used for unknown indication
125519822 12551982 8 Product used for unknown indication
125519822 12551982 9 Product used for unknown indication
125519822 12551982 10 Product used for unknown indication
125519822 12551982 11 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125519822 12551982 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125519822 12551982 Blood creatine phosphokinase increased
125519822 12551982 Muscle atrophy
125519822 12551982 Muscular weakness
125519822 12551982 Myalgia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125519822 12551982 1 20141003 0
125519822 12551982 2 20141003 0
125519822 12551982 3 20160322 20160327 0
125519822 12551982 4 20160506 0
125519822 12551982 5 20141003 0
125519822 12551982 6 20150724 0
125519822 12551982 7 20160603 20160604 0
125519822 12551982 8 20141003 0
125519822 12551982 9 20160506 20160603 0
125519822 12551982 10 20141003 0
125519822 12551982 11 20141003 0